246 related articles for article (PubMed ID: 18390869)
1. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation.
Gasparini M; Auricchio A; Metra M; Regoli F; Fantoni C; Lamp B; Curnis A; Vogt J; Klersy C;
Eur Heart J; 2008 Jul; 29(13):1644-52. PubMed ID: 18390869
[TBL] [Abstract][Full Text] [Related]
2. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.
Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA
Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438
[TBL] [Abstract][Full Text] [Related]
3. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.
Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z
Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182
[TBL] [Abstract][Full Text] [Related]
5. Atrio-ventricular junction ablation and pacemaker treatment: a comparison between men and women.
Carnlöf C; Insulander P; Jensen-Urstad M; Iwarzon M; Gadler F
Scand Cardiovasc J; 2018 Jun; 52(3):120-126. PubMed ID: 29537317
[TBL] [Abstract][Full Text] [Related]
6. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
[TBL] [Abstract][Full Text] [Related]
7. Cardiac resynchronization therapy in patients with permanent atrial fibrillation. Is it mandatory to ablate the atrioventricular junction to obtain a good response?
Tolosana JM; Arnau AM; Madrid AH; Macias A; Lozano IF; Osca J; Quesada A; Toquero J; Francés RM; Bolao IG; Berruezo A; Sitges M; Alcalá MG; Brugada J; Mont L;
Eur J Heart Fail; 2012 Jun; 14(6):635-41. PubMed ID: 22396459
[TBL] [Abstract][Full Text] [Related]
8. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.
Stavrakis S; Garabelli P; Reynolds DW
Europace; 2012 Oct; 14(10):1490-7. PubMed ID: 22696519
[TBL] [Abstract][Full Text] [Related]
9. Complete atrioventricular block does not reduce long-term mortality in patients with permanent atrial fibrillation treated with cardiac resynchronization therapy.
Tolosana JM; Trucco E; Khatib M; Doltra A; Borras R; Castel MÁ; Berruezo A; Arbelo E; Sitges M; Matas M; Guasch E; Brugada J; Mont L
Eur J Heart Fail; 2013 Dec; 15(12):1412-8. PubMed ID: 23845796
[TBL] [Abstract][Full Text] [Related]
10. Predictors of hospitalization for heart failure and of all-cause mortality after atrioventricular nodal ablation and right ventricular pacing for atrial fibrillation.
Björkenheim A; Brandes A; Andersson T; Magnuson A; Edvardsson N; Wandt B; Sloth Pedersen H; Poçi D
Europace; 2014 Dec; 16(12):1772-8. PubMed ID: 25031234
[TBL] [Abstract][Full Text] [Related]
11. Comparison of survival for cardiac resynchronization therapy in atrial fibrillation patients with or without atrio-ventricular junction ablation and patients in sinus rhythm: a systematic review and network meta-analysis.
Xue Y; Wang J; Wang J; Thapa S; Huang K; Peng Y; Qian L; Li J; Ji K
Heart Fail Rev; 2019 May; 24(3):335-342. PubMed ID: 30610455
[TBL] [Abstract][Full Text] [Related]
12. Cardiac resynchronization therapy and atrial fibrillation.
Kamath GS; Steinberg JS
Cardiol J; 2009; 16(1):4-10. PubMed ID: 19130410
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of atrio-ventricular junction ablation in patients with permanent atrial fibrillation.
Foley PW; Leyva F
Eur Heart J; 2008 Sep; 29(17):2182; author reply 2182-3. PubMed ID: 18586662
[No Abstract] [Full Text] [Related]
14. Impact of chronic atrial fibrillation in patients with severe heart failure and indication for CRT: data of two registries with 711 patients (1999-2006 and 2007-6/2008).
Luedorff G; Grove R; Kowalski M; Wolff E; Thale J; Kranig W
Herzschrittmacherther Elektrophysiol; 2011 Dec; 22(4):226-32. PubMed ID: 22160274
[TBL] [Abstract][Full Text] [Related]
15. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS.
Brignole M; Pokushalov E; Pentimalli F; Palmisano P; Chieffo E; Occhetta E; Quartieri F; Calò L; Ungar A; Mont L;
Eur Heart J; 2018 Dec; 39(45):3999-4008. PubMed ID: 30165479
[TBL] [Abstract][Full Text] [Related]
17. Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients?
Abreu A; Oliveira M; Silva Cunha P; Santa Clara H; Portugal G; Gonçalves Rodrigues I; Santos V; Morais L; Selas M; Soares R; Branco L; Ferreira R; Mota Carmo M;
Rev Port Cardiol; 2017 Oct; 36(10):687-694. PubMed ID: 29031455
[TBL] [Abstract][Full Text] [Related]
18. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations.
Gasparini M; Kloppe A; Lunati M; Anselme F; Landolina M; Martinez-Ferrer JB; Proclemer A; Morani G; Biffi M; Ricci R; Rordorf R; Mangoni L; Manotta L; Grammatico A; Leyva F; Boriani G
Eur J Heart Fail; 2018 Oct; 20(10):1472-1481. PubMed ID: 29251799
[TBL] [Abstract][Full Text] [Related]
19. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
[TBL] [Abstract][Full Text] [Related]
20. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
